REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Compania Servimed Asr Cia.Ltda (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Compania Servimed Asr Cia.Ltda Profile Updated: May 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Compania Servimed Asr Cia.Ltda is based in Ecuador. The head office is in Quito. The company operates in the Pharmaceutical and Medicine Manufacturing sector. It was first established on January 08, 2019. There are currently 3 (2023) people employed by Compania Servimed Asr Cia.Ltda. The latest financial highlights indicate a net sales revenue drop of 28.91% in 2023. Its’ total assets recorded a negative growth of 6.62%. The enterprise’s net profit margin increased by 13.24% in 2023.

Headquarters
las Alondras 200
Quito; Pichincha;

Contact Details: Purchase the Compania Servimed Asr Cia.Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Compania Servimed Asr Cia.Ltda report to view the information.
Outstanding Shares:
Purchase the Compania Servimed Asr Cia.Ltda report to view the information.
Registered Capital:
Purchase the Compania Servimed Asr Cia.Ltda report to view the information.
Incorporation Date:
January 08, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99%
Purchase this report to view the information.
1%
Company Performance
Financial values in the chart are available after Compania Servimed Asr Cia.Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-28.91%▼
Total operating revenue
-30.38%▼
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
57.11%▲
Total assets
-6.62%▼
Total equity
48.52%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
13.24%▲
Return on Equity (ROE)
2.27%▲
Quick Ratio
1.34%▲
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo